ABSTRACT. The nuclear membrane is one of the major cellular barriers in the delivery of plasmid DNA (pDNA). Cell division has a positive influence on the expression efficiency since at the end of mitosis, pDNA or pDNA containing complexes near the chromatin are probably included by a random process in the nuclei of the daughter cells. However, very little is known about the nuclear inclusion of nanoparticles during cell division. Using the Xenopus nuclear envelope reassembly (XNER) assay, we found that the nuclear enclosure of nanoparticles was dependent on size (with 100 nm and 200 nm particles being better included than the 500 nm ones) and charge (with positively charged particles being better included than negatively charged or poly-ethyleneglycolated (PEG-ylated) ones) of the 2 beads. Also, coupling chromatin-targeting peptides to the polystyrene beads or pDNA complexes improved their inclusion by 2-to 3-fold. Upon microinjection in living HeLa cells, however, nanoparticles were never observed in the nuclei of cells post-division but accumulated in a specific perinuclear region, which was identified as the lysosomal compartment. This indicates that nanoparticles can end up in the lysosomes even when they were not delivered through endocytosis. To elucidate if the chromatin binding peptides also have potential in living cells, this additional barrier first has to be tackled, since it prevents free particles to be present near the chromatin at the moment of cell division.
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KEYWORDS. cell division, nuclear enclosure, Xenopus laevis, HeLa cells, pDNA delivery, nuclear exclusion, exocytosis INTRODUCTION. Gene therapy shows potential in the treatment of a wide variety of genetic disorders. For gene therapy to be successful, the nucleic acids should reach their target, which is situated intracellularly. Naked nucleic acids are poorly taken up by cells. Therefore, they are administered by using viral or non-viral vectors. In general, viral vectors provide high transfection efficiencies but suffer from the limited amount and size of the genetic material they can carry. Also, they can induce severe immune responses. Non-viral vectors are advantageous over viral vectors in that they are less expensive, easier and safer to make and more suitable for long time storage. They can also deliver much larger pieces of DNA when compared to viral methods 1 . Non-viral vectors mostly enter the cells by endocytosis. Then, they have to escape from the endosomal compartment and release their therapeutic DNA in the cytoplasm of the cells. Furthermore, the therapeutic DNA should stay intact and reach its target, which is the nucleus in the case of plasmid DNA (pDNA). Plasmid DNA delivery and expression remain challenging despite many years of non-viral gene therapy research. Although non-viral systems have many advantages, their expression efficiency is very low when compared to viral systems. Factors which decrease expression efficiency include cytoplasmic sequestration (by interactions with DNA binding proteins and cytoskeletal elements) 2, 3 , enzymatic degradation 4 , decomplexation from carrier 3 molecules 5 and most importantly, lack of transport across the nuclear membrane, which is one of the major cellular barriers 6, 7 . In non-dividing cells, the transfer through the nuclear pore complexes (NPCs) of intact nuclear envelopes is very inefficient. Many studies suggest that although it is not impossible, larger molecules such as pDNA do not readily cross NPCs 2, [8] [9] [10] [11] . Several attempts at improving non-viral entry of pDNA into the nucleus have been published, in which nuclear localization signal (NLS)
containing proteins or peptides were attached to the pDNA by electrostatic interactions 12 or covalent binding 13 . Also, attachment to cellular DNA binding proteins including histones 14 and high-mobility group (HMG) proteins 15 , as well as DNA containing the Simian Virus 40 (SV40) promoter and origin of replication 16 Interestingly, several groups have observed that the expression efficiencies of cationic lipid-, polymerand peptide-based transfection reagents were two-to several hundred-fold higher in dividing as compared to non-dividing cells , have been investigated. These attempts at improving the transport of DNA to the nucleus have however met with limited success. 9, 11, [17] [18] [19] [20] [21] [22] [23] [24] . Also, cell division had a positive influence on the nuclear inclusion of colloidal gold particles 25 . This suggests that transfection close to M phase is perhaps facilitated by nuclear membrane breakdown, since the disassembly of the nuclear envelope during cell division most likely facilitates access to the nucleoplasm and chromatin. It is plausible that the naked pDNA or nanoparticles near the chromatin are included by chance in the nuclei of the daughter cells during mitosis, as is presented in figure 1 .
Figur e 1. Principle of nuclear inclusion during cell division. (Black) nanoparticles, (green) nuclear membrane, (red) golgi-apparatus and (blue) chromatin.
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Previous studies which focused on the fate of nanoparticles and the dependence of their characteristics in living cells, mostly delivered the nanoparticles through uptake by endocytosis. It was reported, for example, that the pathway of internalization depends on the size of the polystyrene nanoparticles 26 .
Furthermore, the uptake mechanism, uptake rate, cytotoxicity and exocytosis of gold nanoparticles of different size and shape were investigated 27, 28 . Recently, Errington and colleagues studied the fate of nanoparticles during the cell cycle. The quantum dots were asymmetricly and non-random diluted over daughter cells which is probably related to a survival mechanism of the cell responding to stress 29 .
Although the nuclear inclusion appears a very simple concept to study, very little is known on the nuclear entry of nanoparticles during cell division. How and to what extent can nanoparticles access the nucleoplasm during cell division? Is nuclear inclusion random or do nanoparticles need to interact with chromatin to be enclosed? Do the nanoparticles remain in the nucleoplasm during subsequent cell cycles? Many of these questions remain unanswered, although they are highly relevant for non-viral gene delivery. We addressed these open questions by studying to which extent nanoparticles are enclosed in artificial Xenopus laevis nuclei and in daughter nuclei of dividing HeLa cells. The Xenopus nuclear assembly reaction (XNER assay) functions as a model system, in which the enclosure of nanoparticles in fully functional artificial nuclei can be studied in the most ideal situation, e.g. without the presence of additional extracellular and intracellular barriers. In case of the HeLa cells the nanoparticles were microinjected into the cytosol so as to avoid additional intracellular barriers such as cellular uptake and endosomal escape, and to prevent that particles would be trapped inside endosomes through endocytic uptake. We investigated whether the size and charge of the nanoparticles had an influence on the nuclear inclusion and if the enclosure could be enhanced by modification of the nanoparticles by using chromatin binding peptides since one might expect more efficient enclosure by binding to the chromatin during cell division.
MATERIAL AND METHODS.
Green fluorescent carboxylated polystyrene beads (Molecular Probes®) of different size (100, 200 and 500 nm) were used. These beads have a negative ζ-potential and were modified with Pluronic F-127 (Sigma-Aldrich®) and dimethylamine-ethylamine (DMAEA) to obtain respectively polyethyleneglycolated (PEG-ylated)
Polystyrene beads 30 and positively charged beads (see Table 1 ). The latter is the result of an amide formation between the carboxylate groups on the beads and the amine group of DMAEA. The carboxylate groups were activated with an excess of EDC at pH 5. DMAEA (at pH 5) was added and this was shaken overnight. Then, Microcon-YM-100 (Millipore®) were used to purify the positively charged beads. These series of beads are called 'non-targeted beads'. Additionally, the carboxylated 100 nm beads were modified via a NH 2 -PEG-maleimide linker with 3 gluthatione-S-transferase (GST)-tagged peptides, namely Mel-28, mutated Mel-28 or HMGA2β ( Fig. 2A) . Briefly, 10 mg/ml NH 2 -PEGmaleimide (creative PEGworks) was added to 500 µl 0.4 % solution of the carboxylated beads and incubated overnight at 4 °C. Then, the beads were purified by centrifugation over Microcon-YM-100 columns and recollected after 2 washing steps by reversed centrifugation. The modified beads were incubated overnight with 50 µg of glutathion-GST-tagged proteins to allow binding to the maleimide side of the NH 2 -PEG-maleimide linker. The beads were again purified by centrifugation over Microcon-YM-100 columns and recollected after 2 washing steps by reversed centrifugation. Further on, these beads are called 'targeted beads'. Mel-28, mutated Mel-28 and HMGA2β were prepared as described elsewhere 31 . Diameter and ζ-potential measurements of the non-targeted beads were done with a ZETASIZER NANO (Malvern Instruments).
As pDNA nanoparticles we made use of pDNA complexed to 7.5 kDa linear poly-ethylene-imine were incubated overnight at 4 °C with 13.5 µg of glutathion-GST-tagged peptides to allow binding to the maleimide side of the NHS-PEG-maleimide linker so that chromatin targeted PEI polymers were obtained. In this concentration, almost all glutathion-GST-tagged peptides bound to the PEI polymers, which makes further purification unnecessary. To be sure, however, the PEI complexes were additionally purified by centrifugation over Microcon-YM-100 columns and recollected after 2 washing steps by reversed centrifugation before use. The diameter and ζ-potential of the non-targeted and targeted pDNA/PEI polyplexes were measured with a ZETASIZER NANO (Malvern Instruments).
The initial chromatin binding properties of Mel-28, mutated Mel-28 and HMGA2β were evaluated with immunostaining against the GST-fragment of the AT-hooks. Membrane-free extract was supplemented with GST alone or GST-AT-hooks at 1 µM final concentration, and incubated with chromatin for 10 minutes. Then, the chromatin was fixed with 4 % PFA in PBS for 10 minutes. The fixed chromatin was placed on top of 0.8 ml 30 % sucrose cushion in PBS and centrifuged onto poly-Llysine coated cover slips. Blocking was carried out for 30 minutes in 1 % BSA-PBS. Then, the samples were incubated with the primary anti-GST antibody in 1 % BSA-PBS for 2 hours, followed by extensive washing before the fluorescein-labelled secondary antibody (in 1 % BSA-PBS) was added for 1 hour.
Immunostaining of GST-AT-hooks
After washing, the chromatin was stained by adding 0.1 µg/ml DAPI and the samples were visualized with a fluorescence microscope.
Cytosolic extract and membrane fraction needed for the XNER assay were isolated from Xenopus laevis eggs and sperm chromatin was prepared from Xenopus leavis sperm (Xenopus laevis testis were also kindly provided by Kris Vleminckx Lab, VIB, Ghent) as previously described by Hetzer et al.
Xenopus nuclear envelope reassembly (XNER) assay 32 .
To study the nuclear inclusion in the XNER assay, 1 µl of polystyrene beads (green) or Cy5- 
RESULTS.
As non-targeted nanoparticles, we made use of polystyrene beads of 100, 200 and 500 nm as this is the size range in which most of the non-viral gene delivery complexes are situated. Initially, also polystyrene beads of 20 and 40 nm were included in the study, as model particles that should be able to cross the NPCs. However, due to problems of functionalization, aggregation and detection of these weakly fluorescent particles, these smaller particles were omitted from the further study.
Characteristics of non-targeted and targeted nanoparticles
First, the carboxylated polystyrene beads, as bought from the manufacturer, were functionalized to obtain positively charged or PEG-ylated beads. In table 1, the mean diameter (nm) and ζ-potential (mV) of these different kinds of nanoparticles are presented. It can be seen that for a given size, the negatively charged beads are always slighty larger than stated by the manufacturer. Also, making the beads positively charged or PEG-ylated results in a further size increase. The ζ-potential demonstrates that we indeed succeeded in making positively charged particles. In the case of PEG-ylated particles, the ζ-potential becomes less negative due to the presence of the PEG-chains. Size (nm) 577 ± 4 608 ± 10 589 ± 3 233 ± 1 249 ± 2 248 ± 2 116 ± 1 134 ± 1 122 ± 2 168 ± 10 131 ± 6 154 ± 7 238 ± 6 ζ (mV) -52 ± 1 -29 ± 1 26 ± 1 -47 ± 1 -30 ± 1 26 ± 1 -45 ± 2 -23 ± 1 29 ± 1 29 ± 3 21 ± 2 22 ± 2 17 ± 2
Apart from polystyrene beads, also pDNA/PEI nanoparticles were used as a model for non-viral gene delivery vehicles. PEI was chosen as complexation partner for the pDNA to form pDNA/PEI polyplexes as it is a well-characterized polymer for gene delivery which is hypothesized to be able to enter the nucleus during transfection 33 . To obtain chromatin targeted nanoparticles, both the 100 nm beads and the pDNA/PEI polyplexes were modified with chromatin binding peptides. As chromatin targeting peptides, part of the proteins Mel-28, mutated Mel-28 or HMGA2β were chosen. These peptides contain an AT-hook, a DNA binding motif found in a family of proteins that binds the minor groove of the ATrich scaffold-associated regions (SARs) on metaphase chromosomes 34 . Mel-28 is associated with two types of structures in the cell, one implicated in nuclear-envelope function and the other in chromatin organization, and is recruited to chromatin at an early time point during nuclear assembly 35, 36 .
HMGA2β is a small non-histone chromatin-associated protein that belongs to the family of the HMG proteins, architectural factors which regulate the chromatin structure by specifically binding and bending the DNA and creating active and inactive chromatin regions which are essential for gene expression [37] [38] [39] . Figure 2A shows the sequences of the AT-hooks which were used. The specific targeting of Mel-28 (GST-AT) and HMGA2β (GST-AT HMGA2β ) to the chromatin can be seen after immunostaining of the GST-fragment of the chromatin targeting peptides ( Figure 2B ), while GST alone, or GST-tagged mutated Mel-28 (GST-AT MUT ) does not stain the chromatin. Table 1 also contains the mean diameter (nm) and ζ-potential (mV) of the pDNA/PEI polyplexes before and after functionalization with the chromatin targeting peptides. It can be seen that the charge of the functionalized polyplexes slightly decreases, while the size slightly decreases for Mel28 and mutated
Mel28, but increases for HMGA2β. Due to the small sample volume and cost of material, the diameter and ζ-potential of the targeted beads could not be measured. The artificial nuclei (Fig. 3) are obtained with the Xenopus nuclear envelope reassembly (XNER)
assay. In this assay, sperm chromatin is first mixed with cytosolic extract which results in a partial decondensation of the sperm chromatin. It should be noted that Xenopus sperm chromatin is much more compact than normal mitotic chromatin but is spontaneously repackaged with histones in the cytosolic Nuclear inclusion of non-targeted polystyrene beads with different size/charge in the XNER assay 11 extract to become normal mitotic chromatin [40] [41] [42] [43] [44] . Then, upon the addition of membrane extract and an ATP generating buffer, the membrane fractions bind to the chromatin and eventually fuse so that nuclear membranes are formed around the chromatin material. Then, the chromatin decondenses further and nuclear proteins are imported resulting in the swelling of the nuclei so that functional artificial nuclei are formed 40, 41, [43] [44] [45] [46] Figure 3 shows representative examples of artificial nuclei obtained with the XNER assay. Depending on where in the sample the pictures are taken, more or less membrane elements or beads seem to be present, although the total number of particles and membrane elements in each situation is comparable.
Also, only fully decondensed nuclei (> 25 µm) were counted as the smaller ones represent unfinished nuclei and should not be taken into account. Between 50 and 100 of these large, functional nuclei were analyzed for each experiment with a different type of nanoparticles. The results are summarized in figure 4 showing the percentage of nuclei containing 0, between 1 and 5, between 6 and 10, or more than 10 nanoparticles. It can be seen, in figure 3 as well as in figure 4 , that from time to time the nontargeted beads are enclosed in the artificial nuclei but enclosure is rather limited. Nevertheless, size and charge do have an influence on nuclear entry (Fig. 4) . The enclosure of the positively charged beads is higher than the enclosure of the negatively charged or the PEG-ylated ones. Apart from the charge, it can be seen that also size matters, beads with a diameter of 200 nm and 100 nm were better enclosed than the 500 nm ones. Thus, the diameter, volume and/or weight can impair the inclusion. We conclude that small (100 -200 nm) positively charged beads have the best chance to be retained in the nucleus upon cell division.
. By addition of fluorescently labelled nanoparticles to the XNER assay, we could evaluate the efficiency with which different types of nanoparticles are entrapped in the formed nuclei.
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In these experiments, not only the inclusion in the artificial nuclei, but also the initial binding to chromatin before adding the membrane fraction to the XNER assay was determined. Figure 5A shows that the enclosure of beads modified with the chromatin binding peptides derived from Mel-28 or We were interested to see whether polystyrene beads (100 nm) and pDNA/PEI complexes which are present in the cytoplasm, gain access to the nucleus during cell division. Since figure 5A and B show that even for non-targeted positively charged nanoparticles about 45 % of the particles that bind to chromatin are retained in the formed nuclei, we would expect to find at least some chromatin binding particles in the nuclei of the daughter cells. To circumvent endocytosis and the need for endosomal escape, the non-targeted nanoparticles were delivered by directly injecting them into the cytoplasm of HeLa cells. Injection solutions were supplemented with TRITC-dextran to identify the place of injection and whether or not injected cells divide. Figure 6 shows representative images of the intracellular distribution of 100 nm positively charged polystyrene beads (green) and pDNA/PEI polyplexes (red) during cell division, in injected living HeLa cells. Initially, the polystyrene beads spread through the cytoplasm, while the pDNA/PEI complexes remained closer to the place of injection (indicated by an arrow). Also, the pDNA/PEI complexes can be seen to 'line up' at the nuclear membrane, demonstrating that they are not 'pushed' through the NPCs by the applied injection pressure. Upon cell division, it can be seen that both the polystyrene beads and the pDNA/PEI complexes are evenly distributed over the two daughter cells, but accumulate in the perinuclear region of the daughter cells, rather than being present in the nuclei of these cells. Indeed, enclosure of nanoparticles in the nuclei of cells which had undergone division was never observed. This is in contrast to the nuclear inclusion seen in assembled Nuclear inclusion of microinjected polystyrene beads and pDNA/PEI polyplexes in HeLa cells 15 nuclei in the XNER assay, where there were about 10 pDNA/PEI complexes present in the case of nontargeted complexes (see Fig. 5B ). Apart from non-targeted nanoparticles, also nanoparticles targeted with HMGA2β were used for microinjection (Fig. 6C ). HMGA2β was chosen as the data in figure 5 pointed out that in this case, the largest fraction of chromatin-bound nanoparticles is retained in the formed nuclei. Also here, however, the nanoparticles were never observed in the nuclei of divided cells, but again accumulated in this specific perinuclear region. Whether the nanoparticles first reach the nuclear interior and are then expelled to this perinuclear region, or accumulate in this perinuclear region already before cell division occurs is not clear. Identification of the specific perinuclear region where nanoparticles tend to accumulate
Since we found that the injected polystyrene beads or pDNA/PEI complexes both accumulate in a specific perinuclear region, we were interested to determine what this perinuclear region could be.
Therefore, we performed staining of cell compartments such as the early endosomes and the lysosomes.
To prevent overlap between the staining colour and the injected beads, red fluorescent beads were injected instead of green ones. Colocalization of the red and the green channel was determined in Image J after a background subtr act, so that colocalized pixels appear white, while non-colocalized pixels appear green or red in the overlay image. Figure 7A shows that there is no colocalization between the injected beads and the early endosomes: no white pixels are found in the colocalization image. When the lysosomes were stained, however, a great amount of colocalization was observed after 24 hours of incubation (Fig. 7C ). This is an interesting observation which implies that nanoparticles can end up in the lysosomal compartment even when they are directly injected in the cytoplasm and not taken up by endocytosis. When the colocalization with the lysosomes was evaluated immediately after injection, no colocalization was found (Fig. 7B) , indicating that the colocalization observed after 24 hours is not an clogging and long-term survival of the cells after injection. Using the cell-free XNER assay (which is the only way to isolate the process of nuclear inclusion), however, we were able to investigate the influence of size and charge of nanoparticles on their nuclear inclusion and found that 100 or 200 nm particles were more efficiently included than those of 500 nm. We hypothesize that smaller particles are due to their smaller size more efficient in penetrating the more narrow regions in the condensed chromatin. Therefore, they have access to a larger surface of the chromatin and can be anchored more easily e.g. when they are surrounded by chromatin in those grooves. For a given size, positively charged nanoparticles were most efficiently included in the nuclei, followed by the negatively charged or PEGylated ones, which can most likely be explained by aspecific interactions of the positively charged beads with the negatively charged chromatin. It should be noted that for both the positively and negatively charged beads, interactions of the beads with poly-ions or proteins of the cytosolic extract, before nuclear reassembly starts, could influence the overall charge and nuclear inclusion of the beads. This could explain why the negatively charged beads are better included then the PEG-ylated ones, since the inert PEG-chains lack the possibility to interact with the cytosolic poly-ions, proteins or chromatin material during the reassembly reaction, although the PEG-ylated beads also possessed a slightly negative charge (see table 1 ). Furthermore, we were able to demonstrate that nanoparticles or pDNA/PEI complexes which are targeted to the chromatin have about 2-3 times higher probability of being retained in the artificial nuclei. However, not all the particles which were first bound to the chromatin, were finally included in the nuclei. Most likely, adding the membrane fraction, which is the next step in the XNER assay, results in competition for binding to the chromatin, causing the majority of chromatin-bound nanoparticles (purple bars in Fig. 5 ) to dissociate from the chromatin when the nuclear membrane formation proceeds. Figur e 5 shows that a higher number of pDNA/PEI complexes is enclosed in the ar tificial nuclei when compar ed to polystyrene beads. This can be the r esult of multiple factor s. We believe this can be r elated to the heter ogeneity of the pDNA/PEI complexes, which can influence the char ge distr ibution on their sur face, the size and the shape of the complexes. The r esulting lar ger sur face or char ge density is expected to give r ise to mor e effective binding and ther efore inclusion of the complexes to a lar ger extent. Additionally, it is not unlikely that the pr esence of DNA itself accounts for a gr eat deal for the differ ences obser ved between the pDNA/PEI complexes and the polystyrene beads. Par tially exposed DNA in the pDNA/PEI complexes could for example be anchored to the chr omatin thr ough the inter action with DNA binding pr oteins.
Based on these observations in the XNER assay, we conclude that it should be possible to bring nanoparticles into the nuclei of dividing cells, providing that they are not too large and are able to bind to the chromatin either by their intrinsic positive charge or through the use of chromatin binding peptides. However, unlike with the XNER assay, nuclear inclusion in dividing HeLa cells was never observed. Instead, the nanoparticles accumulated in a perinuclear region, which corresponds to the lysosomal compartment as evidenced by colocalization experiments. Two hypotheses could explain the lack of nuclear inclusion and the specific perinuclear distribution observed in living cells: 1) the nanoparticles are trafficked to the perinuclear region even before cell division occurs and are therefore not free but separated from the chromatin during cell division or 2) the nanoparticles are included in the nuclei during cell division but are expelled from the nuclei and subsequently accumulate in the perinuclear region. To examine these hypotheses, extensive, detailed real-time analysis of the intracellular distribution of the microinjected nanoparticles would be needed. The first hypothesis is favoured by the observation that the nanoparticles are present in the perinuclear region where typically also lysosomes and endosomal vesicles accumulate. This would imply that after microinjection, the foreign nanoparticles are r ecognized by the endosomal machinery and are entrapped in lysosomal vesicles which traffic to the perinuclear region and physically separate the nanoparticles from the chromatin during cell division. Nativo and colleagues also detected that a large population of one of their modified gold nanoparticles group in the vicinity of the nucleus. They stated these were associated to damaged or aberrant endosomes 48 . In relation to recent studies which indicate that nanoparticles are potent autophagy activators, the vesicles we observe can be part of cytoplasmic secretion, exocytosis or autophagy, a process by which the cell recycles and subsequently degrades its own components and 20 clears itself of nanoparticles 49 . Chithrani and colleagues showed that nanoparticles about to be removed from cells appeared to be localized in late endosomes and lysosomes 27 . Also, this could explain the differences between the observations in the XNER assay and living cells, since in cell-free systems, mitotic spindles are totally absent and the influence of endocytosis/autophagy cannot be studied. This shows that we should not assume results obtained from cell-free studies will all apply to living cells, in which additional barriers have to be taken into account 41, 50 The second hypothesis would imply that the nanoparticles can bind the chromatin, but that there is a mechanism which is able to remove the nanoparticles again so that they are not included in the maturated nuclei. Or the chromatin binding is not strong enough to hold the 'big' nanoparticles or there must be a yet unknown 'eliminating' mechanism. Ludtke et al. and Swanson et al. showed that after cytoplasmic delivery by microinjection or scratch-loading, the bulk of labelled pDNA or dextran (> 40 kDa) remained cytoplasmic regardless of cell division. After nuclear injection, however, the labelled pDNA or dextran (> 40 kDa) was nuclear in undivided cells, but mainly cytoplasmic in divided cells
. We do believe, however, that the XNER assay is a valuable platform for testing 'new' chromatin or nuclear targeting vehicles, because it isolates the nuclear envelope reassembly without the influence of other barriers such as cellular uptake or endosomal escape. 51, 52 , supporting the idea that only the chromosomes themselves and macromolecules physically associated with them were included in the newly formed nuclei 52, 53 . They did not mention the possibility that the macromolecules can be inside immatur e nuclei and can be excluded later. In contrast, Gasiorowski and
Dean have shown that naked, unmodified pDNA microinjected directly into the nucleus was able to partition evenly to the two daughter nuclei, but that this postmitotic nuclear retention was altered by DNA labelling methods, resulting in nuclear exclusion of labelled pDNA, while non-modified pDNA was retained 54 . In this study, we cannot exclude that the labelling of our pDNA has an influence on the nuclear exclusion of our pDNA/PEI polyplexes. It should be noted, however, that in our study the labelled pDNA is mainly present in the core of the pDNA/PEI polyplexes and is therefore not expected to significantly alter the intracellular behavior of these particles. Also in the case of the labelled 21 polystyrene beads the fluorophores are present inside the core of the nanoparticles and is not expected to influence the intracellular distribution of these beads.
In summary, although nuclear inclusion was observed in the XNER assay, we hypothesize that in living cells the nanoparticles are either intracellularly 'trapped' in vesicles and are thus not free to bind to the chromatin, or do indeed enter the nuclei of dividing cells, but are again expelled and then accumulate in the lysosomal compartment. The nature of the mechanism that prevents the nuclear inclusion of nanoparticles in living HeLa cells, is a topic that requires further study. It is, however, an interesting observation that nanoparticles which were injected in the cytoplasm of cells end up in the lysosomal compartment, even when they are not taken up by endocytosis. This implies the possibility to "endocytose" nanoparticles which are free in the cytosol, a mechanism which requires further investigation as this is highly relevant towards all sorts of gene delivery vehicles. We do believe,
however, that nuclear inclusion should be possible when the nanoparticles are free in the cytoplasm at 
